It does not follow that because homegrown is Schedule I marijuana-based pharmaceuticals should be as well. We should welcome any relaxation of the marijuana laws, however incremental. Allowing companies to research and bring these new drugs to market will only strengthen the case for rescheduling marijuana: the more people being treated by pot, the more ridiculous the government's contention that it has no medicinal value will seem. NORML sometimes takes delight in pointing out government hypocrisy, even if they shoot themselves in the foot. This is one of those instances.